6-K 1 form6-k.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16

Under the Securities Exchange Act of 1934

For the Month of November 2022

001-40614

(Commission File Number)

INTERCURE LTD.

(Exact name of Registrant as specified in its charter)

85 Medinat ha-Yehudim Street

Herzliya, 4676670, Israel

Tel: +972 77 460 5012

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____

Exhibit Index

Exhibit No. |  | Description
99.1 |  | Unaudited Interim Consolidated Financial Statements for the Period Ended September 30, 2022
99.2 |  | Management’s Discussion and Analysis of Financial Condition and Results of Operations for the Period Ended September 30, 2022
99.3 |  | Form 52-109F2 – Certifications of Interim Filings
99.4 |  | Press Release dated November 15, 2022: InterCure Announces Record Breaking Third Quarter Financial Results

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

| Intercure Ltd.
Date: November 16, 2022 | By: | /s/ Amos Cohen
|  | Amos Cohen
|  | Chief Financial Officer